An Na, Xu Mingzhi, Chen Ruman, Wang Cuijuan, Bai Yafei
Blood Purification Center of Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570311, China.
Mediators Inflamm. 2025 Jul 27;2025:9021628. doi: 10.1155/mi/9021628. eCollection 2025.
Sepsis-induced acute kidney injury (S-AKI), a life-threatening complication of systemic infection, is driven by macrophage-mediated inflammatory dysregulation. This study explores the role of heat shock binding protein 21 (HBP21) in attenuating renal injury through PI3K/AKT pathway modulation, employing cellular and animal models to dissect its therapeutic mechanisms and clinical relevance. In vitro, RAW264.7 cells underwent LPS-induced M1 polarization, and HBP21 expression was manipulated to evaluate its role in macrophage phenotype and PI3K/AKT signaling activation. M1/M2 macrophage polarization was quantified by flow cytometry, while coculture with NRK-52E cells evaluated tubular epithelial cell viability (CCK-8) and apoptosis (flow cytometry). An S-AKI rat model was induced via cecal ligation and puncture (CLP). Renal function (serum creatinine [Scr]/blood urea nitrogen [BUN]), tissue damage (hematoxylin and eosin [H&E]/terminal dUTP nick-end labeling [TUNEL]), and inflammation (Western blot/IHC) were systematically analyzed. HBP21 overexpression promoted M2 macrophage polarization and activated PI3K/AKT signaling in LPS-stimulated macrophages. Knockdown of HBP21 obtained the opposite data. Inhibition with LY294002 or activation with 740 Y-P reversed these effects, confirming pathway involvement. Cocultured NRK-52E cells exposed to conditioned medium from HBP21-overexpressing macrophages showed a 62.32% increase in viability and a 56.11% reduction in apoptosis under LPS challenge. HBP21 overexpression in vivo lowered Scr (38.5%) and BUN (47.4%), alleviated tubular damage, and shifted renal macrophages toward an M2 anti-inflammatory phenotype with concurrent TNF-α/IL-6 downregulation. These findings suggest that HBP21 mitigates S-AKI pathogenesis via PI3K/AKT-mediated M2 macrophage polarization, underscoring its translational potential in renal injury therapy.
脓毒症诱导的急性肾损伤(S-AKI)是一种危及生命的全身感染并发症,由巨噬细胞介导的炎症失调驱动。本研究利用细胞和动物模型探讨热休克结合蛋白21(HBP21)通过PI3K/AKT途径调节减轻肾损伤的作用,剖析其治疗机制和临床相关性。在体外,RAW264.7细胞经脂多糖(LPS)诱导发生M1极化,通过调控HBP21表达来评估其在巨噬细胞表型和PI3K/AKT信号激活中的作用。采用流式细胞术对M1/M2巨噬细胞极化进行定量分析,同时与NRK-52E细胞共培养,通过细胞计数试剂盒-8(CCK-8)评估肾小管上皮细胞活力,通过流式细胞术评估细胞凋亡情况。通过盲肠结扎和穿刺(CLP)诱导建立S-AKI大鼠模型。系统分析肾功能(血清肌酐[Scr]/血尿素氮[BUN])、组织损伤(苏木精-伊红染色[H&E]/末端脱氧核苷酸转移酶介导的缺口末端标记法[TUNEL])和炎症反应(蛋白质免疫印迹法/免疫组化法)。HBP21过表达促进LPS刺激的巨噬细胞向M2巨噬细胞极化并激活PI3K/AKT信号。敲低HBP21则得到相反的数据。使用LY294002抑制或740 Y-P激活可逆转这些效应,证实该途径的参与。在LPS刺激下,暴露于HBP21过表达巨噬细胞条件培养基中的共培养NRK-52E细胞活力增加62.32%,细胞凋亡减少56.11%。体内HBP21过表达可降低Scr(38.5%)和BUN(47.4%),减轻肾小管损伤,并使肾巨噬细胞向M2抗炎表型转变,同时肿瘤坏死因子-α/白细胞介素-6下调。这些发现表明,HBP21通过PI3K/AKT介导的M2巨噬细胞极化减轻S-AKI发病机制,凸显其在肾损伤治疗中的转化潜力。